These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7809531

  • 1. [Frequency of lumbar spine osteopenia in an asymptomatic postmenopausal Chilean population].
    Arteaga E, Campusano C, Rodríguez JA, Cervilla V, López JM, Valdivia G.
    Rev Med Chil; 1994 Apr; 122(4):372-7. PubMed ID: 7809531
    [Abstract] [Full Text] [Related]

  • 2. [High prevalence of osteoporosis in asymptomatic postmenopausal Mapuche women].
    Ponce L, Larenas G, Riedemann P.
    Rev Med Chil; 2002 Dec; 130(12):1365-72. PubMed ID: 12611237
    [Abstract] [Full Text] [Related]

  • 3. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women.
    Sadat-Ali M, Al-Habdan I, Al-Mulhim AA, El-Hassan AY.
    Saudi Med J; 2005 Oct; 26(10):1588-90. PubMed ID: 16228061
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density and osteoporosis in rural and urban women. Epidemiological study of the Lublin region (Eastern Poland).
    Filip RS, Zagórski J.
    Ann Agric Environ Med; 2001 Oct; 8(2):221-6. PubMed ID: 11748880
    [Abstract] [Full Text] [Related]

  • 5. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women.
    Sumino H, Ichikawa S, Kasama S, Takahashi T, Sakamoto H, Kumakura H, Takayama Y, Kanda T, Murakami M, Kurabayashi M.
    Hypertens Res; 2008 Jun; 31(6):1191-7. PubMed ID: 18716368
    [Abstract] [Full Text] [Related]

  • 6. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD.
    CMAJ; 2007 Sep 11; 177(6):575-80. PubMed ID: 17846439
    [Abstract] [Full Text] [Related]

  • 7. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE.
    Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460
    [Abstract] [Full Text] [Related]

  • 8. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.
    Menopause; 2003 Mar 20; 10(4):337-44. PubMed ID: 12851517
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
    Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M.
    Saudi Med J; 2004 Oct 20; 25(10):1423-7. PubMed ID: 15494815
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of skeletal size of the lumbar spine on areal bone density, volumetric bone density, and the diagnosis of osteoporosis in postmenopausal women in China.
    Liao EY, Wu XP, Liao HJ, Zhang H, Peng J.
    J Bone Miner Metab; 2004 Oct 20; 22(3):270-7. PubMed ID: 15108071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Biochemical markers of bone remodeling and bone density in healthy postmenopausal women].
    Campusano C, López JM, González G, Rojas A, Arteaga E, Rodríguez J.
    Rev Med Chil; 1993 Sep 20; 121(9):1000-5. PubMed ID: 8191148
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
    Anaforoglu I, Nar-Demirer A, Bascil-Tutuncu N, Ertorer ME.
    J Diabetes Complications; 2009 Sep 20; 23(1):12-7. PubMed ID: 18413190
    [Abstract] [Full Text] [Related]

  • 16. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ, Laitinen K, Patronen A, Puolijoki H, Seppänen J, Pylkkänen L, Aranko SM, Sairanen S, Blåfield H, Rekiaro M, Väisänen K, Kormano M, Mäkinen L, Salmi J, Ala-Kaila K, Perttilä J, Vesterinen K, Koivunoro K, Probone Study Group.
    Osteoporos Int; 2002 Dec 20; 13(12):937-47. PubMed ID: 12459936
    [Abstract] [Full Text] [Related]

  • 17. Heritability of bone mineral density.
    François S, Benmalek A, Guaydier-Souquières G, Sabatier JP, Marcelli C.
    Rev Rhum Engl Ed; 1999 Mar 20; 66(3):146-51. PubMed ID: 10327493
    [Abstract] [Full Text] [Related]

  • 18. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S, Karner I.
    Medscape Womens Health; 2001 Oct 20; 6(5):3. PubMed ID: 11698925
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA, Okumuş B, Osmanagaoglu T, Bozkaya H.
    J Womens Health (Larchmt); 2004 Nov 20; 13(9):993-9. PubMed ID: 15665656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.